E

ENCell Co Ltd
KOSDAQ:456070

Watchlist Manager
ENCell Co Ltd
KOSDAQ:456070
Watchlist
Price: 15 350 KRW -6.86% Market Closed
Market Cap: 163.5B KRW
Have any thoughts about
ENCell Co Ltd?
Write Note

ENCell Co Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ENCell Co Ltd
Operating Expenses Peer Comparison

Comparables:
207940
S
237690
F
220100
L
141080
C
268600

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
E
ENCell Co Ltd
KOSDAQ:456070
Operating Expenses
-â‚©11.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Operating Expenses
-â‚©786.8B
CAGR 3-Years
-73%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
ST Pharm Co Ltd
KOSDAQ:237690
Operating Expenses
-â‚©72.1B
CAGR 3-Years
-19%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Operating Expenses
-â‚©10.8B
CAGR 3-Years
-5%
CAGR 5-Years
0%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Operating Expenses
-â‚©113.9B
CAGR 3-Years
-10%
CAGR 5-Years
-27%
CAGR 10-Years
-30%
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Operating Expenses
-â‚©18.6B
CAGR 3-Years
2%
CAGR 5-Years
-25%
CAGR 10-Years
N/A

See Also

What is ENCell Co Ltd's Operating Expenses?
Operating Expenses
-11.4B KRW

Based on the financial report for Dec 31, 2023, ENCell Co Ltd's Operating Expenses amounts to -11.4B KRW.

What is ENCell Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 1Y
-14%

Over the last year, the Operating Expenses growth was -14%.

Back to Top